Početna › Mentalni poremećaji › Florida
Kliničke studije za Mentalni poremećaji u državi Florida
7 studija za Mentalni poremećaji traži sudionike na lokacijama u državi Florida.
Gradovi u državi Florida
Službeni tekst studije (engleski)
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Brandon, Florida, Brandon
- Miami, Florida, Miami
- Miami, Florida, Miami
- i još 5
U tijeku regrutacijaFaza 2/3
Od 18 do 70 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07598708A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Boca Raton
- Clinical Site, Deerfield Beach
- Clinical Site, Doral
- i još 11
U tijeku regrutacijaFaza 2
Od 55 do 90 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT06887192A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Hollywood
- Clinical Site, Hollywood
- Clinical Site, Miami
- i još 2
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 1. ruj 2026. · NCT07459647A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- K2 Medical Research, LLC, Maitland
- Charter Research, LLC, The Villages
U tijeku regrutacijaFaza 1
Od 50 do 85 godina · Oba spola · Ažurirano 24. kol 2026. · NCT06297590A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- CenExel, Hollywood
- Bioresearch Partner, Miami
- University of South Florida, Psychiatry and Behavioral Neurosciences, Tampa
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 11. svi 2026. · NCT06524830A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder
- Vistagen Clinical Site, Largo
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 5. velj 2026. · NCT06809179Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Maitland
- GSK Investigational Site, Miami
- GSK Investigational Site, Stuart
U tijeku regrutacijaFaza 2
Od 50 do 85 godina · Oba spola · Ažurirano 2. velj 2026. · NCT07105709Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.